Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Belizean Rose Apple (*Syzygium aqueum*) is rich in bioactive compounds such as flavonoids (e.g., myricetin-3-O-rhamnoside), phenolic acids, and tannins. These compounds primarily exert their effects through potent antioxidant, anti-inflammatory, and antidiabetic mechanisms, notably via α-glucosidase inhibition.
Reported Benefits (Provisional)
Origin & History
Belizean Rose Apple, *Syzygium jambos*, is native to the tropical regions of Belize, thriving in warm climates and fertile soils. This small, bell-shaped fruit is cherished for its delicate floral aroma and crisp texture. It is highly valued for its hydrating, antioxidant, and immune-boosting properties, making it significant for functional nutrition.
Research Narrative (Provisional)
Scientific research on *Syzygium jambos* focuses on its antioxidant profile, dietary fiber content, and Vitamin C levels. Studies investigate its potential in supporting digestion, boosting immunity, and reducing inflammation, aligning with its traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C, Vitamin A - Minerals: Potassium, Magnesium - Macronutrients: Dietary Fiber - Phytochemicals: Flavonoids, Phenolic compounds
Reported Mechanism (Provisional)
The therapeutic effects of Belizean Rose Apple are largely attributed to its rich profile of flavonoids like myricetin-3-O-rhamnoside and quercetin, along with phenolic acids, tannins, and anthocyanins. These compounds neutralize free radicals to reduce oxidative stress and modulate inflammatory pathways. Notably, specific flavonoids such as myricetin-3-O-rhamnoside demonstrate significant α-glucosidase inhibitory activity, contributing to its antidiabetic potential.
Clinical Narrative (Provisional)
While *in vitro* studies have identified potent bioactive compounds in *Syzygium aqueum* with antioxidant, anti-inflammatory, and antidiabetic properties, human clinical trials are currently limited. Research has primarily focused on the chemical composition and preliminary *in vitro* activity, such as the α-glucosidase inhibition by myricetin-3-O-rhamnoside (IC₅₀=1.1 μM). Further controlled clinical studies are needed to substantiate these findings and establish efficacy and optimal dosages in human subjects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.